The dual role of the cAMP-dependent protein kinase C alpha subunit in T-cell receptor-triggered T-lymphocytes effector functions
- PMID: 1281154
The dual role of the cAMP-dependent protein kinase C alpha subunit in T-cell receptor-triggered T-lymphocytes effector functions
Abstract
In order to directly evaluate the role of the cAMP-dependent protein kinase (PKA) catalytic (C) subunit in T-cell receptor- (TCR) triggered cytotoxic T-lymphocytes (CTL) effector functions, cells were studied after pretreatment with antisense oligomers complementary to mRNA for the C alpha or C beta subunits. C alpha subunit is shown to be predominantly expressed in CTL. In some experiments the pretreatment of the CTL with the C alpha antisense, but not with the control or C beta antisense oligomers, resulted in the inhibition of cAMP-independent PKA activity without significantly affecting the level of total cAMP-inducible PKA activity. In parallel assays, CTL which were pretreated with the C alpha antisense oligomer had enhanced antigen-bearing target cell-triggered-, anti-TCR monoclonal antibody-triggered-, and phorbol 12-myristate 13-acetate/A23187-triggered exocytosis of granules, as well as enhanced antigen-specific cytotoxicity. In contrast, the TCR-triggered gamma-interferon mRNA expression and gamma-interferon secretion were inhibited in C alpha antisense-pretreated CTL. These results suggest that the C alpha subunit of PKA may have a dual role in regulation of T-lymphocytes effector functions: (i) it may down-regulate TCR-triggered protein-synthesis independent responses such as cytotoxicity and exocytosis, thereby counteracting TCR-triggered activation even in the absence of the second messenger, cAMP, and (ii) the C alpha subunit activity is likely to be required for the nuclear and/or cytoplasmic events in CTL's activation involved in lymphokine synthesis and secretion.
Similar articles
-
Perturbation of the expression of the catalytic subunit C alpha of cyclic AMP-dependent protein kinase inhibits TCR-triggered secretion of IL-2 by T helper hybridoma cells.J Immunol. 1997 Jan 1;158(1):171-9. J Immunol. 1997. PMID: 8977188
-
Locus of inhibitory action of cAMP-dependent protein kinase in the antigen receptor-triggered cytotoxic T lymphocyte activation pathway.J Biol Chem. 1988 Feb 15;263(5):2330-6. J Biol Chem. 1988. PMID: 2448308
-
The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.J Immunol. 1989 Jan 15;142(2):416-24. J Immunol. 1989. PMID: 2492047
-
Mechanistic, functional and immunopharmacological implications of biochemical studies of antigen receptor-triggered cytolytic T-lymphocyte activation.Immunol Rev. 1988 Mar;103:127-60. doi: 10.1111/j.1600-065x.1988.tb00754.x. Immunol Rev. 1988. PMID: 3134292 Review.
-
Induction of lytic pathways in T cell clones derived from wild-type or protein tyrosine kinase Fyn mutant mice.Immunol Rev. 1995 Aug;146:117-44. doi: 10.1111/j.1600-065x.1995.tb00687.x. Immunol Rev. 1995. PMID: 7493751 Review.
Cited by
-
Inhibition of T cell cAMP formation by cyclosporin A and FK506.Naunyn Schmiedebergs Arch Pharmacol. 1996 Apr;353(5):513-6. doi: 10.1007/BF00169170. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8740144
-
Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A(2).Cell Mol Immunol. 2010 Jan;7(1):77-82. doi: 10.1038/cmi.2009.105. Epub 2009 Dec 23. Cell Mol Immunol. 2010. PMID: 20029460 Free PMC article.
-
Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma.Cancer Immunol Immunother. 1995 Feb;40(2):79-87. doi: 10.1007/BF01520288. Cancer Immunol Immunother. 1995. PMID: 7882386 Free PMC article.
-
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells.Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S457-64. doi: 10.1038/bjp.2008.23. Br J Pharmacol. 2008. PMID: 18311159 Free PMC article. Review.
-
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.Purinergic Signal. 2007 Mar;3(1-2):129-34. doi: 10.1007/s11302-006-9044-9. Epub 2007 Jan 24. Purinergic Signal. 2007. PMID: 18404426 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources